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Abstract: The risk of type 2 diabetes associated with obesity appears
to be influenced by other metabolic abnormalities, and there is con-
troversy about the harmless condition of the metabolically healthy obese
(MHO) state. The aim of this study is to assess the risk of diabetes and
the impact of changes in weight and in triglyceride-glucose index (TyG
index), according to the metabolic health and obesity states.
We analyzed prospective data of the Vascular Metabolic CUN
cohort, a population-based study among a White European population
(mean follow-up, 8.9 years). Incident diabetes was assessed in 1923
women and 3016 men with a mean age at baseline of 55.33 13.68 and
53.78 12.98 years old.
A Cox proportional-hazard analysis was conducted to estimate the
hazard ratio (HR) of diabetes on metabolically healthy nonobese
(MHNO), metabolically healthy obese, metabolically unhealthy non-
obese (MUNO), and metabolically unhealthy obese (MUO). A con-
tinuous standardized variable (z-score) was derived to compute the HR
for diabetes per 1-SD increment in the body mass index (BMI) and the
TyG index.
MHO, MUNO, and MUO status were associated with the develop-
ment of diabetes, HR of 2.26 (95%CI: 1.25–4.07), 3.04 (95%CI: 1.69–
5.47), and 4.04 (95% CI: 2.14–7.63), respectively. MUNO individuals
had 1.82 greater risk of diabetes compared to MHO subjects (95% CI:
1.04–3.22). The HRs for incident diabetes per 1-SD increment in BMI
and TyG indexes were 1.23 (95% CI: 1.04–1.44) and 1.54 (95% CI:
1.40–1.68). The increase in BMI did not raise the risk of developing
diabetes among metabolically unhealthy subjects, whereas increasing
the TyG index significantly affect the risk in all metabolic health
categories., MD, Alejandro F ero, MD, PhD,
d Jose Alfredo Martinez, MD, PhD
(Medicine 95(19):e3646)
Abbreviations: BMI = body mass index, BP = blood pressure, CI =
confidence interval, CUN = University of Navarra Clinic, FPG =
fasting plasma glucose, HDL-C = HDL cholesterol, HOMA-IR =
homeostatic model assessment of insulin resistance, HR = hazard
ratio, IR = insulin resistance, LDL-C = LDL cholesterol, MHNO =
metabolically healthy nonobese, MHO = metabolically healthy
obese, MUNO = metabolically unhealthy nonobese, MUO =
metabolically unhealthy obese, SD = standard deviation, TC = total
cholesterol, TG = triglycerides, TyG index = triglyceride-glucose
index, VMCUN cohort = Vascular Metabolic CUN cohort.
INTRODUCTION
T he link between generalized or central obesity and insulinresistance is currently accepted.1 However, some obese
individuals appear to be at low risk of metabolic-related com-
plications, whereas normal-weight individuals may not cer-
tainly be ‘‘healthy.’’ In this context, 2 terms have been used
to identify the different statuses regarding metabolism and body
size: metabolically healthy obese (MHO) and metabolically
unhealthy nonobese (MUNO) individuals.2,3 Among obese
individuals, those with preserved insulin sensitivity and lower
inflammatory profile are classified as MHO.4,5 Subjects with
higher levels of insulin resistance and adiposity, unfavorable
lipid profile, and higher levels of proinflammatory cytokines are
classified as MUNO.6,7 However, there is little agreement on
the definition of metabolic health and obesity states leading to
inconsistency in prevalence among the studies.8,9 In addition,
there is controversy about the harmless condition of the MHO
phenotype. Some studies have reported thatMHO subjects had a
greater risk of incident diabetes than nonobese subjects,10–12
whereas others have contradicted these results.13–15 Moreover,
these are not stable conditions, and changes in body weight or
metabolic health status might lead to different health con-
sequences. Indeed, some studies have indicated that a pro-
portion of those MHO at baseline might have been at the
initial period of a metabolically unhealthy state.16
The triglyceride-glucose index (TyG index), the product of
fasting plasma glucose and triglycerides, has been suggested as
a marker of moderate insulin resistance,17 correlated with the M
rates in the hyperinsulinaemic-euglycaemic clamp test 18 and
with the homeostatic model assessment of insulin resistance
(HOMA-IR).19 This measurement has also been suggested as a
candidate marker for classifying the metabolic health status 20
and, recently, Lee et al 21 showed that changes in the TyG index
over time altered the incidence and risk of diabetes.
Therefore, the aim of this study was to assess the incidence
of type 2 diabetes according to the metabolic health and obesity
status of 4939 free diabetes participants during 8.86 years ofdied the impact of the gain in body mass
TyG index on the risk of developing type
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METHODS
Subjects
The Vascular Metabolic CUN cohort (VMCUN cohort) is a
population-based, epidemiological study designed to examine
the incidence of cardiovascular and metabolic diseases includ-
ing type 2 diabetes, hypertension, obesity, stroke, or coronary
heart disease in a large White European population. The cohort
has been described elsewhere.22 Briefly, exclusion criteria were
age <18 or >90 years, history of type 1 diabetes or latent
autoimmune diabetes in adults, cancer in the palliative phase,
familial hypertriglyceridemia, extreme BMI (>45 kg/m2), or a
hypercoagulable state. A total of 6071 people fulfilled the
inclusion criteria. We excluded patients with prevalent diabetes,
missing laboratory values, and those subjects lost to follow-up.
Furthermore, since we wanted to study gain in BMI and TyG
index, we restricted our analyses to those who had>1 follow-up
examination. This left 4939 participants for the current analysis
(Figure 1). The research was conducted according to the
standards of the Declaration of Helsinki on medical research
and was approved by the Ethics Committee of the University of
Navarra (30/2015).
MEASUREMENTS
Data regarding medical history, health-related behaviors
and serum biochemical measurements were retrieved at each
patients’ visit. The median of follow-up was 10 years (mean
8.9 4.3 years), with a median number of 3 visits per patient
(range 2–8 visits) and a median time gap of 2 years between
each clinical visit.
Health-related behaviors including cigarette smoking
(none, former smoker, or current smoker), daily alcohol intake
Navarro-Gonza´lez et al(yes/no), and lifestyle pattern (physically active/sedentary beha-
vior) were obtained by physicians at the consultation. Before
the measurement of blood pressure (BP), subjects waited for
FIGURE 1. Flowchart of study participants drawn from the Vasc
CUN¼University of Navarra Clinic.
2 | www.md-journal.com5 minutes in a seated position. The BP on the indistinctly
right or left arm was measured twice and the average value
was recorded following World Health Organization criteria.
Hypertension was defined on the basis of the World Health
Organization-International Society of Hypertension Guide-
lines23 as140 (systolic BP)/90 (diastolic BP) mm Hg or when
the subjects reported use of antihypertensive medication. Car-
diovascular disease was defined according to the International
Classification of Diseases,24 Tenth Revision (ICD-10). The
code list covers diseases from 3 groups: coronary heart disease,
codes from I20 to I25; cerebrovascular disease, codes from I63
to I66; and peripheral arterial disease, codes I73.9 and I74.
Anthropometric measurements and measurements of bio-
chemical parameters including fasting plasma glucose (FPG),
total cholesterol (TC), triglycerides (TG), HDL-cholesterol
(HDL-C), and LDL-cholesterol (LDL-C) were obtained as it
was described elsewhere.22 TG was measured using enzymatic
colorimetric tests, and LDL-C was calculated using the
Friedewald formula.25 The values of LDL-C were considered
as missing in patients with TG levels >400mg/dL. The
TyG index was calculated as the ln[fasting TG (mg/dL) 
FPG (mg/dL)/2].18 The TG/HDL-C ratio was calculated as TG
divided by HDL-C (expressed in mg/dL).
Definitions of Metabolic Health and Obesity
States
Obesity phenotypes were defined according to the World
Health Organization criteria: nonobese <30 kg/m2 and
obese 30 kg/m2.26 The cut off TyG index levels to define a
metabolically healthy state 20 were: TyG index <8.73 for
women and <8.82 for men.
Metabolically healthy state was also defined using the
Medicine  Volume 95, Number 19, May 2016Adult Treatment Panel III (ATP-III) components of the meta-
bolic syndrome.27 The waist circumference (WC) was not used
because of its collinearity with BMI. Participants who met three
ular-Metabolic CUN clinical cohort between 1997 and 2012.
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of the following criteria were considered metabolically healthy:
(1) TG< 150mg/dL; (2) HDL-cholesterol 40mg/dL for men
and 50mg/dL for women; (3) blood pressure (BP)< 130/85
mm Hg; or (4) FPG <100mg/dL. All individuals currently
taking a pharmacological treatment for hypertension were
assumed to have raised BP.
According to these criteria, study participants were cate-
gorized into 1 of 4 categories: (1) metabolically healthy non-
obese (MHNO); (2) metabolically healthy obese (MHO); (3)
metabolically unhealthy nonobese (MUNO); (4) metabolically
unhealthy obese (MUO).
Definition of Incident Diabetes
The diagnosis of type 2 diabetes was defined as the primary
outcome of the study. We diagnosed diabetes according to the
American Diabetes Association (ADA) 28: symptoms of dia-
betes plus random plasma glucose concentration 200mg/dL
(11.1mmol/L), or FPG 126mg/dL (7.0mmol/L), or 2-h post-
load glucose 200mg/dL (11.1mmol/L) during an OGTT.
From February 2010 onwards, we diagnosed diabetes according
to the update ADA criteria published in 2010,29 which include
the criteria of levels of HbA1c 6.5%. Each criterion, in
the absence of unequivocal hyperglycemia, was achieved by
repeated testing on a different day.
Statistical Analysis
BMI and TyG index changes were calculated as the
differences in weight and in the TyG index from each pair
of consecutive visits (e.g., visit 2 minus visit 1, visit 3 minus
visit 2, etc.). Continuous variables were expressed as the mean
 standard deviation (SD). Categorical variables were pre-
sented as percentages. Student’s t test, 1-way ANOVA, or x2
test were used to compare the baseline characteristics of study
participants according to the metabolic health and obesity
status. Age was the underlying time variable and exit-time
was defined as date of diabetes for outcomes or date completing
the last follow-up for survivors. We conducted a Cox pro-
portional-hazard analysis to estimate the hazard ratio (HR) and
their 95% confidence interval (CI) of type 2 diabetes according
to the metabolic health and obesity status. The MHNO category
was used as a reference. We fitted 3 models: a crude (univariate)
model and 2 Cox regression multivariate-adjusted models: (a)
controlling for age (continuous) and sex; (b) additionally
adjusted for baseline BMI (continuous), cigarette smoking
(never, current, and former smokers), daily alcohol intake
(yes/no), lifestyle pattern (physically active/sedentary beha-
vior), hypertension (yes/no), cardiovascular disease (yes/no),
antiaggregation therapy (yes/no), LDL-C (continuous), HDL-C
(continuous), and TG (continuous).
Secondary analyses were conducted to ascertain the impact
of the gain in BMI and in the TyG index on the risk of
developing diabetes. BMI and TyG index changes were
recorded into quintiles. The category containing zero value
was used as the reference group. Linear trend estimation model
was used to fit the median of the quintiles as a continuous
variable to estimate the trend of diabetes incidence across
quintiles. We then derived a continuous standardized variable
(z-score; mean¼ 0, SD¼ 1) to compute the HR for incident
diabetes per 1-SD increment in BMI and TyG indexes. In
addition, we performed stratified analyses in prespecified sub-
Medicine  Volume 95, Number 19, May 2016groups defined by age (<60 vs 60 years old), BMI categories
(normal weight¼ 18.5–24.9 kg/m2, overweight¼ 25–29.9 kg/
m2, and obesity¼ 30 kg/m2 or greater), sex (men vs women),
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.and participants without hypertension and cardiovascular
disease at baseline.
Interaction terms between the metabolic health and
obesity status or BMI and TyG index gained and subgroups
characteristics were tested using likelihood ratio comparing
models with and without multiplicative interaction terms. The
multiple imputation procedure was applied to impute the
missing data of the variables cigarette smoking (16.6%missing
values), daily alcohol intake (25.4% missing values), and
lifestyle pattern (30.8% missing values). Twenty imputed
datasets were created to reduce sampling variability from
the imputation process. The variables included in the imputa-
tion procedure were: age, sex, BMI, cardiovascular disease,
hypertension, TyG index, FPG, TG and the outcome, type 2
diabetes. A run length of 100 iterations was used between each
data set. All the variables included were tested and present a
normal distribution.
All statistical analyses were performed with STATA ver-
sion 12 (Stata Corp., College Station, TX). All P-values are
2-tailed and statistical significance was set at the conventional
cut-off of P< 0.05.
RESULTS
Baseline Characteristics
Data from 1923 women and 3016 men with a mean (SD)
age at baseline of 55.33 13.68 and 53.78 12.98 years were
observed for an average of 9.06 and 8.73 years, respectively.
Baseline clinical and characteristics of the study according
to metabolic health categories are shown in Table 1. Overall,
67% of patients were categorized as MHNO, 14% as MHO,
12% asMUNO, and 7% asMUO. Compared with metabolically
healthy individuals, metabolic unhealthy subjects showed
higher frequencies of antiaggregation therapy, cardiovascular
disease, current smokers, and daily drinkers.
Risk of Incident Type 2 Diabetes According to the
Metabolic Health Categories
There were 406 cases of incident type 2 diabetes during
44115.67 person-years of follow-up (overall incidence of 8.22
% or 9.21 cases/1000 person-years). Incidence was 5.67% for
women and 9.84% for men. The incidence of type 2 diabetes in
the categoryMUOwas twice the incidence ofMHO andMUNO
(Table 2). MHO, MUNO, andMUO status were associated with
the development of diabetes, compared with MHNO. The HR
for the multivariate adjusted model were 2.26 (95% CI: 1.25–
4.07), 3.04 (95%CI: 1.69–5.47), and 4.04 (95%CI: 2.14–7.63),
respectively. The results did not change when the metabolic
health phenotypes were analyzed with the ATP-III criteria.
MUNO individuals had greater risk of incident diabetes com-
pared to MHO subjects, HR 1.82, (95% CI: 1.04–3.22), in the
multivariate adjusted model.
Risk of Incident Type 2 Diabetes and BMI and
TyG Index Change
We found a significant increased risk of diabetes among
the patients with increase of the BMI or TyG index (Table 3).
The HR for incident diabetes for subjects in the fifth quintile of
BMI change (>1.13 kg/m2) and TyG index change (>0.09
units) compared with stable category were 1.74 (95% CI:
BMI and TyG Index Change and Diabetes Risk1.15–2.62) and 4.78 (95% CI: 3.09–7.37), respectively. The
risk of diabetes increased with increasing quintiles of BMI and
TyG index change (P for trend<0.05).
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TABLE 1. Characteristics of Study Participants According to Metabolic Health and Obesity States of 4939 Free-Diabetes
Participants Drawn From the Vascular Metabolic CUN Clinical Cohort Between 1997 and 2012

MHNO MHO MUNO MUO P
n 3319 683 593 344
Demographic data
Sex (% men) 55.9 67.9 73.5 75.3 <0.001
Age, y 53.5 13.9 56.8 12.5 55.6 11.1 55.6 10.4 <0.001
BMI, kg/m2 24.9 2.9 32.6 2.5 26.6 2.2 33.3 2.8 <0.001
Cigarette smoking (%)
Current smokers 31.5 34.1 44.8 40.4 <0.001
Former smokers 17.6 20.2 20.8 25.9 <0.001
Alcohol intake, %
Daily drinkers 44.7 53.2 55.3 63.5 <0.001
Lifestyle pattern, %
Sedentary behavior 49.4 77.2 55.1 80.5 <0.001
Antiaggregation therapy, % 15.4 20.9 23.9 22.4 <0.001
Cardiovascular disease, % 3.1 4.4 6.4 5.5 <0.001
Hypertension, % 20.8 38.4 29.3 44.2 <0.001
TyG index 8.1 0.4 8.3 0.3 9.1 0.3 9.2 0.3 <0.001
Fasting Plasma glucose, mg/dL 93.6 9.6 96.6 10.1 100.4 10.6 102.9 11.0 <0.001
Triglycerides, mg/dL 76.5 27.0 89.9 26.2 184.7 62.2 191.6 66.1 <0.001
LDL-cholesterol, mg/dL 146.7 36.6 152.3 33.9 159.6 40.3 159.2 38.6 <0.001
HDL-cholesterol, mg/dL 58.2 15.0 52.9 13.3 47.7 11.6 45.5 10.3 <0.001
Total cholesterol, mg/dL 219.9 39.8 222.9 36.9 244.2 43.4 242.5 41.9 <0.001
MHNO¼metabolically healthy nonobese, MHO¼metabolically healthy but obese, MUNO¼metabolically unhealthy nonobese,
al v
Navarro-Gonza´lez et al Medicine  Volume 95, Number 19, May 2016The cumulative incidence of diabetes raised proportionally
if BMI increased, TyG index increased (HR: 1.97 [95% CI:
1.31–2.99]), and the increment of both parameters together
(HR: 2.47 [95% CI: 1.74–3.53]) (Figure 2).
The main results of the present study were consistent for
almost all the different scenarios that we included in the
sensitivity analyses (Table 4). Metabolically unhealthy individ-
uals who gained weight during the study did not show an
increased risk of developing diabetes. In contrast, increasing
the TyG index significantly affect the risk of future diabetes in
all metabolic health categories and particularly in obese. The
results were not different when the ATP-III criteria were used to
define the metabolic health status. Only obese individuals who
had gain in BMI showed an increased risk of diabetes, but the
gain in the TyG index significantly increased the diabetes risk,
independently of the BMI at baseline. The association of gain in
BMI or TyG index with the risk of diabetes was similar across
MUO¼metabolically unhealthy and obese.
Plus–minus values are meansSD.
P< 0.05 by 1-way ANOVA (continuous variable) or x2 test (categoricall the subgroups of the study population. Analysis without
hypertension and cardiovascular disease at baseline were per-
formed and the results of our study were not different.
DISCUSSION
In this large cohort study of White European population,
subjects who were metabolically unhealthy (MUNO and MUO)
showed an increased risk of diabetes incidence significantly
greater than those subjects metabolically healthy, obese and
nonobese. The results were similar when using the TyG index or
the ATP-III criteria to define the metabolic health and obesity
status of participants. The gain in BMI and in the TyG index was
positively associated with the development of diabetes. Further-
more, the burden on diabetes incidence was considerably higher
4 | www.md-journal.comif the TyG index was raised. In addition, the increment in
the TyG index was associated with type 2 diabetes in both
metabolically healthy and unhealthy individuals, obese and
nonobese. The gain in BMI was associated with diabetes only
among metabolically healthy individuals.
Results from preceding studies proposed several mechan-
isms to explain the favorable metabolic profile of MHO sub-
jects, such as the preserved insulin sensitivity,30 lower visceral
and ectopic fat distribution,5 lower concentrations of tumor
necrosis factor-a, interleukin-6 or adiponectin,6,7 as well as a
favorable noninflammatory state.4,31 Visceral fat seems to be
the starting point for insulin resistance, where lipolysis is
enhanced and the flux of free fatty acids is altered. On the
other hand, subcutaneous fat appears to protect against insulin
resistance and obesity.32 However, it remains unclear whether
obese individuals who are metabolically healthy have an
increased risk of type 2 diabetes over time. Several studies
have reported that MHO subjects had a greater risk of diabetes
incidence than MHNO subjects,10–12 whereas others have
reported opposite findings.13–15 In fact, some studies have
suggested that MHO status is not a permanent condition but
a transitory state.16,33 In this context, Appleton et al15 showed
that, though MHO subjects had an increased risk of diabetes, it
was mainly among those who progressed to a metabolically
unhealthy state over a time frame follow-up.
The results of this study are in line with foregoing ones
suggesting that MHO would not be a harmless condition,
regarding the development of diabetes and compared to the
MHNO state, but also highlights that MUNO individuals had
ariables).greater risk of incidence in diabetes compared to MHO subjects.
The combination of being metabolically unhealthy and obese
heightens the risk of diabetes incidence. Thus, metabolic health
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 2. Risk of Incident Type 2 Diabetes According to the Metabolic Health and Obesity States of 4939 Free-Diabetes
Participants Drawn From the Vascular Metabolic CUN Clinical Cohort Between 1997 and 2012y
Metabolic Health and Obesity States Based on TyG Index Criteria
MHNO MHO MUNO MUO P for Interactionz
n 3319 683 593 344
Number of incident cases of diabetes 134 84 92 96
Incidence, % 4.04 12.29 15.51 27.91
Person-years 31022.1 5494.6 5015.7 2583.3
Incidence/1000 person-years 4.32 15.29 18.34 37.16
Crude 1 (ref) 3.23 (2.46–4.25)

4.05 (3.09–5.28)

8.34 (6.40–10.85)

<0.001
Age and sex adjusted 1 (ref) 3.21 (2.44–4.22)

3.85 (2.94–5.03)

8.21 (6.29–10.72)

<0.001
Multivariate adjusted model 1 (ref) 2.26 (1.25–4.07)

3.04 (1.69–5.47)

4.04 (2.14–7.63)

<0.001
Metabolic Health and Obesity States Based on ATP-III Criteria
MHNO MHO MUNO MUO P for Interactionz
n 3209 624 703 403
Number of incident cases of diabetes 110 67 116 113
Incidence, % 3.43 10.73 16.50 28.04
Person-years 30136.2 5183.6 5901.6 2894.3
Incidence/1000 person-years 3.65 12.93 19.66 39.04
Crude 1 (ref) 3.33 (2.45–4.52)

4.55 (3.48–5.96)

9.68 (7.37–12.73)

<0.001
Age and sex adjusted 1 (ref) 3.27 (2.41–4.43)

4.59 (3.54–5.97)

9.49 (7.29–12.36)

<0.001
Multivariate adjusted model 1 (ref) 1.65 (1.10–2.46)

3.29 (2.38–4.85)

3.79 (2.44–6.89)

<0.001
MHNO¼metabolically healthy nonobese, MHO¼metabolically healthy but obese, MUNO¼metabolically unhealthy nonobese,
MUO¼metabolically unhealthy and obese.
P< 0.05.
yThe multivariate Cox proportional hazard model was adjusted for age, sex, baseline BMI, cigarette smoking (never, current, and former smokers),
daily alcohol intake (yes/no), lifestyle pattern (physically active/sedentary behavior), hypertension, cardiovascular disease, antiaggregation therapy,
HDL-cholesterol, LDL-cholesterol, and triglycerides.
zMethod: comparisons between groups were performed by the Interaction Expansion (xi) test. P value for interactions is the test of effect
modification between the metabolic subgroups on incident diabetes.
Medicine  Volume 95, Number 19, May 2016 BMI and TyG Index Change and Diabetes Riskstatus is likely to be more important determinant for the risk of
diabetes than BMI.13,34
To our knowledge, few studies have examined the relation-
ship between changes in metabolic health status over time and
the risk of developing diabetes.21,34,35 Our study is apparently
the first to compare the effect of weight gain and metabolic
health change on future development of diabetes.
In line with others studies,15,16,36,37 weight gain was
associated with an increased risk of diabetes in both MHO
and MHNO subjects, but the effect on diabetes incidence was
lower. The lack of association between weight gain and the risk
of diabetes in metabolically unhealthy individuals might be
explained in part by the greater absolute risk for developing
diabetes in this group, such that any additional risk factor was
unlikely to contribute to the overall risk. The underlying insulin
resistance of these metabolically unhealthy individuals could be
another reason involved. Our findings are supported by exper-
imental human studies, which suggested that the development
of hyperinsulinemia and insulin resistance occurs during the
early stage of weight gain.38 In fact, increasing BMI does
increase the hazard ratio for diabetes, but, importantly, the
cumulative incidence rates remain quite low. In contrast, a rise

P< 0.01.in the TyG index resulted in higher rates of incident diabetes
regardless of BMI. However, the gain in BMI does interact with
the increment of TyG index to significantly much higher
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.cumulative incident rates. Recently, Wei et al37 reported that
gaining in BMI was associated with higher risk of diabetes in
the younger compared with middle age groups. Our study
supports this age effect modification on diabetes risk: the raise
in BMI did not improve the risk of diabetes in 60 year-old
subjects, compared with <60 years old. Weight gain at a
younger age may lead to an increase in visceral adiposity
and inflammation, compared with older age.39
Such as an important difference between metabolically
healthy and unhealthy subjects was the higher prevalence for
atherogenic dyslipidemia, determined by lower HDL-choles-
terol and hypertriglyceridemia. This association between
atherogenic lipoprotein abnormalities and the developing of
diabetes was described before.40 In this context, our group has
recently reported the effect of high triglycerides levels on the
risk of diabetes, and the usefulness of the TyG index to early
identify individuals at risk of diabetes.41 The TyG index has
been proposed as a surrogate of IR, significantly correlated with
the M rates in the hyperinsulinemic-euglycemic clamp test,18
with the HOMA-IR,19 as well as with fat distribution, subcli-
nical atherosclerosis 17 and diabetes incidence.42 Lee et al 21
reported that changes in the TyG index over time altered the
incidence and risk of diabetes. In this context, the predictive
power of the TyG index to early identify diabetes onset was
compared with FPG and triglycerides.41 When analyzing the
www.md-journal.com | 5
TABLE 3. Risk of Incident Type 2 Diabetes According to Changes in the Body Mass Index or TyG Index During the Follow-Up of
4939 Free-Diabetes Participants Drawn From the Vascular Metabolic CUN Clinical Cohort Between 1997 and 2012y
Body Mass Index Multivariate
Adjusted Model (HR)
TyG Index Multivariate
Adjusted Model (HR)Quintiles of BMI Change (kg/m2) Quintiles of TyG Index Change (Unit)
Q1 (0.77) 1.09 (0.71–1.67) Q1 (0.06) 1.02 (0.64–1.66)
Q2 (–0.77 to 0.02) 1 (ref) Q2 (-0.06 to 0.01) 1 (ref)
Q3 (0.03–0.60) 1.37 (0.88–2.15) Q3 (0.02–0.04) 1.67 (1.09–2.55)

Q4 (0.61–1.43) 1.85 (1.22–2.82)

Q4 (0.05–0.09) 2.95 (1.96–4.43)

Q5 (>1.43) 1.74 (1.15–2.62)

Q5 (>0.09) 4.78 (3.09–7.37)

P for trendz 0.002 P for trendz <0.001
When BMI gained 1.51 (1.16–1.96)

When TyG index gained 2.82 (2.03–3.54)

For each 10% of BMI gained 1.09 (1.03–1.15)

For each 10% of TyG index gained 1.24 (1.18–1.29)

BMI z-score§ 1.23 (1.04–1.44)

TyG index z-score§ 1.54 (1.40–1.68)

BMI¼ body mass index, CI¼ confidence interval, HR¼ hazard ratio, TyG index¼ triglyceride-glucose index.
P< 0.05.
yThe multivariate Cox proportional hazard model was adjusted for age, sex, baseline BMI, cigarette smoking (never, current, and former smokers),
daily alcohol intake (yes/no), lifestyle pattern (physically active/sedentary behavior), hypertension, cardiovascular disease, antiaggregation therapy,
HDL-cholesterol, LDL-cholesterol, and triglycerides.
zLinear trend estimation model was used to fit the median of the quintiles as a continuous variable to estimate the trend of diabetes incidence across
quintiles.
§z score was calculated to compute the hazard ratio for incident diabetes per 1-SD increment.
Navarro-Gonza´lez et al Medicine  Volume 95, Number 19, May 2016areas under the curves, the P value obtained was statistically
significant, indicating that the TyG index was a better predictor

P< 0.01.than FPG (P¼ 0.004) and triglycerides (P¼ 0.034), when the
glucose level was under 100mg/dL. The areas under the ROC
curves (95% CI) were 0.75 (0.70–0.81) for the TyG index, 0.66
FIGURE 2. Cumulative incidence of diabetes by bodymass index
(BMI) gained, TyG index gained, both or none. Hazard ratio (HR)
and their 95% confidence interval (CI) of developing diabetes
were calculated after adjusting for age, sex, baseline BMI,
cigarette smoking (never, current and former smokers),
daily alcohol intake (yes/no), lifestyle pattern (physically active/
sedentary behavior), hypertension, cardiovascular disease,
antiaggregation therapy, HDL-cholesterol, LDL-cholesterol,
and triglycerides. BMI¼body mass index, CI¼ confidence inter-
val, HR¼hazard ratio, TyG index¼ triglyceride-glucose index.
6 | www.md-journal.com(0.60–0.72) for FPG, and 0.71 (0.65–0.77) for triglycerides,
respectively.
Multiple definitions of metabolic health have been used to
define the metabolic health status.8,9 We used the TyG index to
define metabolically unhealthy individuals based on the results
of previous studies suggesting that the TyG index is a useful
candidate marker for classifying metabolic health status.20
Indeed, when we used the ATP-III definition of metabolic
syndrome to define metabolic health, we did not found differ-
ences. Taking into account the results of this study, we state that
the TyG indexmight be a component in the future definition of a
metabolically healthy status and it might be used to easily
classify individuals as metabolically unhealthy.
The principal strength of this study is the fact that the
anthropometric values and the serum biochemical data were
directly obtained or measured throughout the follow-up period
by trained nurses and physicians in a clinical setting, whereas
other studies used self-reported data, which could lead to errors
and bias. These impartial measurements are crucial for studying
metabolic-weight change over time. As our data were repeated
measurements, we could establish that the weight and metabolic
health change were gradual or uneven during the period of the
study.
On the other hand, this study also has some limitations. We
did not collect data of nutritional habits or energy intake.
Although we have not adjusted for this possible confounding
factor, we used other additional variables to adjust, such as BMI
or cholesterol levels which are indirectly related to nutritional
habits.
Because we could not assess insulin secretion, some
metabolically healthy individuals might have isolated insulin
resistance without the major common metabolic abnormalities.
Thus, we cannot deny the possibility of misclassification of
some participants. That might also have influenced overesti-
mating the HR for diabetes among MHO individuals. However,
studying the changes in BMI and TyG index over time, as well
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 4. Stratified Analysis of Multivariate Hazard Ratios for Type 2 Diabetes as Affected by the Gain in the Body Mass Index or
TyG Indexy,
When BMI Gained When TyG Index Gained
Multivariate
Adjusted Model (HR)
Multivariate
Adjusted Model (HR)
Metabolic health and obesity states based on TyG index criteriaz
MHNO 1.75 (1.12–2.74)

2.73 (1.63–4.56)

MHO 3.37 (1.80–6.33)

4.01 (1.91–8.39)

MUNO 0.88 (0.51–1.54) 2.14 (1.24–3.69)

MUO 0.96 (0.41–2.36) 3.37 (1.75–6.45)

P for interaction 0.003 <0.001
Metabolic health and obesity states based on ATP-III criteriaz
MHNO 1.63 (1.02–2.61)

3.45 (2.01–5.95)

MHO 2.99 (1.43–6.26)

3.83 (1.69–8.67)

MUNO 0.97 (0.58–1.65) 1.96 (1.16–3.31)

MUO 1.40 (0.82–2.43) 2.97 (1.63–5.39)

P for interaction 0.002 <0.001
BMI categories§
Normal weight 1.35 (0.62–2.93) 2.52 (1.12–5.65)

Over weight 1.28 (0.86–1.88) 2.39 (1.51–3.60)

Obese 1.80 (1.11–2.73)

3.09 (1.96–4.88)

P for interaction 0.006 <0.001
Agejj
<60 years old 1.61 (1.12–2.32)

2.72 (1.07–3.95)

60 years old 1.34 (0.90–1.97) 2.40 (1.57–3.68)
P for interaction 0.28 0.46
Sex
Men 1.45 (1.06–1.99)

2.68 (1.93–3.73)

Women 1.58 (0.97–2.51) 2.91 (1.68–5.02)

P for interaction 0.24 0.41
Without hypertension and cardiovascular disease at baseline# 1.73 (1.23–2.45)

2.82 (1.96–3.95)

BMIı¨¼ı¨body mass index, CIı¨¼ı¨confidence interval, HRı¨¼ı¨hazard ratio, TyG indexı¨¼ı¨ triglyceride-glucose index.
P< 0.05.
yMethod: comparisons between groups were performed by the Interaction Expansion (xi) test. P value for interactions is the test of effect
modification between each risk factor on incident diabetes and BMI or TyG index gained.
zThe multivariate Cox proportional hazard model was adjusted for age, sex, baseline BMI, cigarette smoking (never, current, and former smokers),
daily alcohol intake (yes/no), lifestyle pattern (physically active/sedentary behavior), hypertension, cardiovascular disease, antiaggregation therapy,
HDL-cholesterol, LDL-cholesterol, and triglycerides.
§Adjusted for previous covariates, except baseline BMI.
jjAdjusted for previous covariates, except age.
Adjusted for previous covariates, except sex.
#Adjusted for previous covariates, except hypertension, cardiovascular disease, and antiaggregation therapy.
Medicine  Volume 95, Number 19, May 2016 BMI and TyG Index Change and Diabetes Riskas repeated measures, contributed to overcome, at least par-
tially, this possible bias. Also the lack of information on the use
of lipid-lowering therapy or antidiabetic drugs may have influ-
enced the results. However, if this bias explained the findings,
the expected change would be towards the null, not away from
the null.
In conclusion, metabolically unhealthy individuals exhib-
ited a greater risk of diabetes than metabolically healthy obese
individuals. The increase in the TyG index might be more
important for developing diabetes than simply weight gain.
These findings suggest the importance of the metabolic health
status in the risk of diabetes, in contrast of the obesity assessed
P< 0.01.by BMI. Our observations might imply a different intervention
strategy for diabetes prevention according to the different
metabolic health and obesity states.
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